Pharmaceuticals and Life Sciences

IBM Cognos Clinical Trial Enrollment Forecasting Performance Blueprint

Patient enrollment is an ongoing challenge for life sciences organizations. Failure to enroll adequate numbers of patients is a primary reason why some clinical trials fail. Sponsors and CROs need robust forecasting and enrollment analytics that involve collaboration among managers, analysts, and the individual investigator sites. The ability to collect and model enrollment trends and make decisions to shut down or set up additional sites is key to managing a global development portfolio as study designs become more complex and resources become more scarce.

Beyond spreadsheets and existing CTMS technologies

Despite the importance of clinical trial enrollment, many life sciences organizations rely on inadequate technologies and processes to manage it. Custom-designed or commercial Clinical Trials Management Systems (CTMS) often lack the flexibility and forecasting capability to model the entire enrollment picture across a worldwide development portfolio. Consequently, spreadsheets are used for modeling and forecasting, creating these issues:

  • Manual processes introduce substantial control risks
  • The combination of CTMS for collecting actual enrollment and spreadsheets for forecasting or scenario modeling leads to problems of data integrity and information silos
  • Spreadsheets lack enterprise-class functionality such as managed workflow and the ability to push template changes out to hundreds of users simultaneously
  • Keeping multiple systems up to date and synchronized is frustrating, time-consuming, and error-prone
  • Spreadsheets create islands of data, making enterprise-wide reporting a challenge.

Align clinical trials with corporate objectives

Based on industry best practices, Cognos, an IBM company, offers an IBM Cognos Performance Blueprint on Clinical Trial Enrollment Forecasting (CTEF). It provides out-of-the box functionality including dashboards, analytical reports, and a pre-configured data model to facilitate rapid time-to-value. Proven practices in model design greatly reduce investment in implementation time and resources.

The Blueprint helps answer these key questions:

  • Am I forecasting sufficient patient numbers to meet study goals?
  • Are patients being enrolled quickly enough to meet end-points?
  • Which sites are underperforming?
  • What are the leading indicators that would provoke a decision to shut down a site?
  • Do I have the right balance between cost and performance?
  • How much will it cost to get enrollment back on target?

Learn more about the Clinical Trial Enrollment Performance Blueprint.

Find out more about:

Additional Resources:


IBM Cognos Clinical Forecasting Performance Blueprint
Online Demo
Learn proven best practices in enrollment indicators that can affect the progress of costly clinical trials.
Read Now
Healthcare Customer Story Bundle
Success Story
Read how leading healthcare providers such as Martin’s Point and Vitas are increasing profitability and serving patients better with Cognos.
10 Ways to Drive Performance: Pharmaceutical Sales and Marketing
White Paper
It starts with identifying your most valuable customers. It ends with budgets you can trust, and clear metrics you can track and share across your organization.
Pharma Perspectives
Article
A paper that offers perspectives on the pharmaceutical industry. Learn about the move toward targeted consumer-driven strategies in sales and marketing. Also discussed are two Cognos Blueprint solutions for managing costs and patient enrollment in clinical trials.
Driving Game-Changing Financial Performance:A Case Study with MDS Pharma
Web Seminar On-Demand
Learn how one organization introduced performance tools and concepts that allowed it to measure financial and sales KPIs, proactively monitor business operations, and manage its business with near-real-time visibility using dashboard metrics and reports.
Performance Management in Clinical Research
Fact Sheet
See how pharma companies are using IBM Cognos performance management to deliver new drugs faster and at a lower cost
A New Formula for Sales and Marketing in Pharmaceuticals
Fact Sheet
Find out how pharma companies can improve brand performance through effective targeting, field force promotion, and other programs to maximize customer access and impact.